Back to Search Start Over

Lack of association between TCF7L2 gene variants and type 2 diabetes mellitus in a Brazilian sample of patients with the risk for cardiovascular disease.

Authors :
Wunsch C
Dornelles TF
Girardi P
Arndt ME
Genro JP
Contini V
Source :
Endocrine regulations [Endocr Regul] 2019 Jan 01; Vol. 53 (1), pp. 1-7.
Publication Year :
2019

Abstract

Objective: Genetic variants in the transcription factor 7-like 2 (TCF7L2) gene have been described as the most noteworthy ones regarding the type 2 diabetes mellitus (T2DM) liability. This work is aimed to evaluate the association between rs12255372 and rs7903146 polymorphisms and T2DM in patients with cardiovascular disease (CAD) risk.<br />Methods: A sample of six hundred and forty-seven patients that underwent the coronary angiography in a Cardiac Catheterization Lab was evaluated. The patients were investigated for the presence of T2DM and coronary stenosis. The TCF7L2 polymorphisms were genotyped by real-time PCR and the haplotype analysis was performed with the MLOCUS software. All genetic tests were carried out by considering the haplotype combinations in patients divided into three groups: 0 - carrying none disease risk allele, 1 - carrying one or two risk alleles and 2 - carrying three or four risk alleles.<br />Results: No significant associations between TCF7L2 risk haplotypes and the presence of T2DM or CAD were detected.<br />Conclusions: Our results indicate that the TCF7L2 rs12255372 and rs7903146 polymorphisms do not influence T2DM in Brazilian patients with the high risk for CAD. Therefore, we assume that these variants may only be relevant for a specific subgroup of T2DM patients or some particular human population.

Details

Language :
English
ISSN :
1336-0329
Volume :
53
Issue :
1
Database :
MEDLINE
Journal :
Endocrine regulations
Publication Type :
Academic Journal
Accession number :
31517619
Full Text :
https://doi.org/10.2478/enr-2019-0001